Tomaralimab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Tomaralimab Usage And Synthesis

Uses

Tomaralimab (OPN-305) is a humanised anti-TLR2 IgG4 monoclonal antibody. Tomaralimab has the potential for the research of Myelodysplastic Syndromes (MDS)[1].

References

[1] GuillermoGarcia-ManeroMD, et al. A Clinical Study of Tomaralimab (OPN-305), a Toll-like Receptor 2 (TLR-2) Antibody, in Heavily Pre-Treated Transfusion Dependent Patients with Lower Risk Myelodysplastic Syndromes (MDS) That Have Received and Failed on Prior Hypomethylating Agent (HMA) Therapy. Blood, 2018, 798.

Tomaralimab(1449294-76-1)Related Product Information

• Remtolumab
• Samrotamab
• Iodine (131I) Apamistamab
• Disitamab
• Prezalumab
• Tafolecimab
• Praluzatamab
• Placulumab
• Imalumab
• Gimsilumab